OCE ENGAGE: A Project Community Newsletter
A quarterly newsletter for patients living with cancer, survivors, advocates and consumers
Related Articles
LLS | 4 Young Blood Cancer Survivors Look Ahead
Four young adult blood cancer survivors share what they’ve been up to and achieved since receiving the LLS Scholarship for Blood Cancer Survivors.
Nominations
NOMINATE The Giants of Cancer Care ® program, presented by OncLive ®, recognizes and celebrates the individuals who have achieved landmark successes within the global…
Myelodysplastic Syndromes | Blood Cancers Today
Myelodysplastic syndromes (MDS) are diseases of the blood cells and bone marrow. Read the latest news.
Spotlight on Cardio-oncology: Managing CV-related Toxicities In Hematological Malignancies
Learn about managing cardiovascular-related toxicities in hematological malignancies including CLL, lymphoma, amyloidosis, AML & MDS.
FDA Grand Rounds
Highlights monthly webcast presentations for CE credit by FDA scientists from across agency on their cutting-edge scientific research
An Overview of FDA’s Project Facilitate Oncology Expanded Access Progr
On Tuesday, December 12, 2023, CDER’s Office of Communication, Division of Drug Information (DDI) will host a webinar titled: FDA Drug Topics: An Overview of…
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
FDA Broad Agency Announcement: Frequently Asked Questions for Oncology
FDA Broad Agency Announcement: Frequently Asked Questions for Oncology Researchers
Ovarian Toxicity in Premenopausal Adults
This guidance provides recommendations to sponsors regarding measurement of ovarian toxicity using clinical measures and biomarkers of ovarian function